An Experimental Study of Spherical Agglomeration of Benzoic acid And Influence of Process Parameters

Authors

  • Jyothi Thati
  • Vijaya Laxmi Avula
  • Pushpalatha C
  • Sailu Chintha

Abstract

Through the process of drowning-out crystallisation in three partly miscible solvent mixtures, sphere aggregates of benzoic crystal have been successfully created. The mixture of benzoic acid, isopropyl alcohol, and bridging liquid is supplied to an agitated crystallizer with water acting as the anti-solvent. When a substance crystallises, little crystals are formed, and the bridging liquid causes the crystals to group together. Different solvents are utilised because benzoic acid crystals wettably adhere to chloroform, toluene, heptane, and pentane, which are all low solubility in water and chosen as bridge liquids. Investigated are the effects of process variables such solute concentration, temperature, stirring rate, processing duration, volume of bridging liquid, and stirring rate on the characteristics of spherical agglomerates of benzoic acid as part of the standard spherical crystallisation experiment, many sets of tests were carried out to monitor how the particle properties gradually changed. The current investigation demonstrates that the bridging liquid significantly affects the product qualities since it allows the formation of spherical agglomerates with four different solvents (chloroform, toluene, heptane, and pentane) when utilised in adequate quantities. When the BSR is 0.72, the particle morphology changes to become spherical; when toluene is employed as the bridging liquid, the particle morphology is totally spherical. With increasing temperature particle size is decreasing. Spherical agglomerates are obtained at 1100 rpm. At 5°C, particles became spherical. Morphology grew as temperature decreased.

References

Y. Kawashima. C.E. Capes. An experimental study of spherical agglomeration in a stirred vessel.1974; 10 (1–2) 85–92

Kawashima Y. Capes CE. Further studies of the kinetics of spherical agglomeration in a stirred vessel. Powder Technol. 1976; 13, 279–288.

Chow AHL, Leung MWM. A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders. Drug DevIndPharma. 1996; 4, 357–371.

Muller M, Loffler F. Development of agglomerate size and structure during spherical agglomeration suspension. Part. Part. Syst. Charact. 1996; 13, 322–326.(6)

Holmbäck X, Rasmuson ÅC. Size and morphology of benzoic acid crystals produced by drowningout crystallization. J.Crystal Growth. 1999; 198-199, 780–788

Kawashima Y, Imai M, Takeuchi H, Yamamoto H, and Kamiya, K, Development of Agglomerated Crystals of Ascorbic acid by the Spherical Crystallization Technique for Direct Tableting, and

Evaluation of their Compactibilities, Kona. 2002; 20, 251–261.

Blandin AF, Mangin D, Rivoire A, Klein JP, Bossoutrot JM. Modeling of agglomeration in suspension: Application to salicylic acid microparticles. Powder Technol. 2005; 156, 19–33.

Subero CC, Mangin D, Rivoire A, Blandin AF, Klein JP. Agglomeration in suspension of salicylic acid fine particles: Analysis of the wetting period and effect of the binder injection mode on the

final agglomerate size. Powder Technol. 2006; 161, 98–109.

Oliveira CA, Coelho GM, Pires FR, Franco JR, Solubility of benzoic acid in mixed solvents. J. Chem. Eng. Data. 2007; 52, 298–300.

Kumar S, Chawla G, Bansal AK. Spherical crystallization of mebendazole to improve process ability. Pharm. Dev. Technol. 2008; 13, 559–568.

B. Kovačič, et al, Particle Size Reduction Technologies in the Pharmaceutical Development Process. Drug is Dichloromethane (DCM), Acta Phamaceutica Sinica B 2012; 1–14.

SumantSaini, ‘Spherical Crystallization: An Overview’, International Journal of Drug Delivery Technolog. 2017; 4(4).

J Thati, S Chintha, A Review on Spherical Crystallization Mechanisms and Characterization, Research Journal of Pharmacy and Technology 11 (1), 412-417, DOI:10.5958/0974– 360X.2018.00076.8

Downloads

Published

2022-09-03

Issue

Vol. 9 No. 2 (2022)

Section

Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.